PER
Click for more information
5.88% 8.0¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says FDA lifts hold for multiple sclerosis drug study

  1. Hot News
    190,158 Posts.
    lightbulb Created with Sketch. 2787
    clock Created with Sketch.
    02/10/17
    10:15
    Post #: 27589158

    Oct 2 (Reuters) - Antisense Therapeutics Ltd (ANP) :

    • Advised by FDA that full clinical hold for phase IIb clinical study of ATL1102 for multiple sclerosis has been lifted
    • Co's application to conduct clinical trial of ATL1102 has been approved by Human Research Ethics Committee
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SVL Silver Mines models five new calderas close to 396Moz Bowdens deposit
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
-0.005(5.88%) 		Mkt cap ! $72.12M
Open High Low Value Volume
8.1¢ 8.1¢ 8.0¢ $47.42K 590.5K

Buyers (Bids)

No. Vol. Price($)
2 34238 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 94978 1
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.